Selective intraarterial infusion chemotherapy in a patient with maxillary carcinoma under artificial hemodialysis

Takahiro Suzuki, Kiyoto Shiga, Toshimitsu Kobayashi

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    When antineoplastic drugs are administered to a patient with impaired or unstable renal function, problems related to the dosage schedule may occur because of differences in pharmacokinetics between patients with normal renal function and those with renal dysfunction. We performed selective intraarterial infusion chemotherapy for a patient with maxillary squamous cell carcinoma who was undergoing hemodialysis for chronic renal failure. Cisplatin at doses of 50 mg/body and docetaxel at doses of 20 mg/body were administered via the maxillary artery twice at a one-week interval. The effect of intraarterial infusion chemotherapy was partial response. We could carry out the subsequential surgery and radiation therapy without severe adverse effects.

    Original languageEnglish
    Pages (from-to)439-444
    Number of pages6
    JournalPractica Oto-Rhino-Laryngologica
    Volume99
    Issue number6
    DOIs
    Publication statusPublished - 2006 Jan 1

    Keywords

    • Cisplatin
    • Docetaxel
    • Hemodialysis
    • Maxillary carcinoma

    ASJC Scopus subject areas

    • Otorhinolaryngology

    Fingerprint Dive into the research topics of 'Selective intraarterial infusion chemotherapy in a patient with maxillary carcinoma under artificial hemodialysis'. Together they form a unique fingerprint.

  • Cite this